cobalt has been researched along with everolimus in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (83.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Brugaletta, S; Cequier, A; de Belder, A; de la Torre Hernandez, JM; Eberli, F; Ferrante, G; Galatius, S; Kaiser, C; Sabaté, M; Serruys, PW; Valgimigli, M | 1 |
| Chan, KH; Chan, M; Fang, WY; Lee, CH; Li, RG; Low, A; Qu, XK; Richards, AM; Tan, HC | 1 |
| Abdelghani, M; Onuma, Y; Serruys, PW; Sotomi, Y; Suwannasom, P; Tateishi, H; Tenekecioglu, E | 1 |
| Alshaker, H; Arafat, T; Böhler, T; Cooper, C; Kawano, Y; Pchejetski, D; Wang, Q; Winkler, M | 1 |
| de Winter, RJ; Dijkstra, J; Kimura, T; Kozuma, K; Miyazaki, Y; Onuma, Y; Popma, JJ; Serruys, PW; Sotomi, Y; Tanabe, K | 1 |
| Asano, T; de Winter, RJ; Dijkstra, J; Jonker, H; Katagiri, Y; Kimura, T; Kozuma, K; Miyazaki, Y; Onuma, Y; Popma, JJ; Serruys, PW; Sotomi, Y; Stone, GW; Tanabe, K; Tenekecioglu, E; Wykrzykowska, JJ | 1 |
| Dean, LS; Krishnan, SK | 1 |
| Aizawa, Y; Fujita, S; Fuse, K; Hatada, K; Ikeda, Y; Kishi, S; Matsubara, T; Okabe, M; Sato, T; Takahashi, M | 1 |
| Fusazaki, T; Hayashi, T; Hibi, K; Ishihara, S; Ito, Y; Kataoka, T; Kikuchi, T; Kuriyama, N; Morino, Y; Morita, T; Otake, H; Otsuka, Y; Shinke, T; Suzuki, T; Tanabe, K; Tanaka, H; Terashita, D | 1 |
| Aoki, J; Awata, M; Kimura, T; Kozuma, K; Kusano, H; Nanasato, M; Nie, H; Shiode, N; Tanabe, K; Yamaguchi, J | 1 |
| Angiolillo, DJ; Baber, U; Bangalore, S; Bhatt, DL; Chandiramani, R; Claessen, BE; Ge, J; Guedeney, P; Hermiller, J; Kozuma, K; Krucoff, M; Liu, Y; Makkar, R; Mehran, R; Neumann, FJ; Rau, V; Saito, S; Seth, A; Sorrentino, S; Valgimigli, M; Vogel, B; Wang, J | 1 |
| Hayashi, T; Hibi, K; Ishida, M; Ito, Y; Itoh, T; Kikuchi, T; Morino, Y; Morita, T; Okamura, T; Otake, H; Sawada, T; Shinke, T; Shite, J; Suzuki, T; Takahashi, F; Terashita, D; Tsukiyama, Y | 1 |
2 review(s) available for cobalt and everolimus
| Article | Year |
|---|---|
Effects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: patient level meta-analysis.
Topics: Chromium; Cobalt; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Humans; Myocardial Infarction; Sirolimus; Stents; Thrombosis; Treatment Outcome | 2014 |
Differential aspects between cobalt-chromium everolimus drug-eluting stent and Absorb everolimus bioresorbable vascular scaffold: from bench to clinical use.
Topics: Absorbable Implants; Chromium; Cobalt; Drug-Eluting Stents; Everolimus; Humans; Mechanotransduction, Cellular; Percutaneous Coronary Intervention; Treatment Outcome | 2015 |
1 trial(s) available for cobalt and everolimus
| Article | Year |
|---|---|
Fate of post-procedural malapposition of everolimus-eluting polymeric bioresorbable scaffold and everolimus-eluting cobalt chromium metallic stent in human coronary arteries: sequential assessment with optical coherence tomography in ABSORB Japan trial.
Topics: Absorbable Implants; Aged; Chromium; Cobalt; Coronary Angiography; Coronary Stenosis; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Japan; Linear Models; Male; Metals; Middle Aged; Normal Distribution; Percutaneous Coronary Intervention; Postoperative Complications; Prospective Studies; Prosthesis Design; Prosthesis Failure; Risk Assessment; ROC Curve; Single-Blind Method; Tomography, Optical Coherence | 2018 |
9 other study(ies) available for cobalt and everolimus
| Article | Year |
|---|---|
Comparison of platinum chromium everolimus-eluting stent with cobalt chromium everolimus-eluting stent in unselected patients undergoing percutaneous coronary intervention.
Topics: Aged; Chromium; Cobalt; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platinum; Radiography; Treatment Outcome | 2015 |
Everolimus (RAD001) sensitizes prostate cancer cells to docetaxel by down-regulation of HIF-1α and sphingosine kinase 1.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Survival; Cobalt; Docetaxel; Dose-Response Relationship, Drug; Down-Regulation; Drug Resistance, Neoplasm; Drug Synergism; Everolimus; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice, Inbred BALB C; Mice, Nude; Phosphotransferases (Alcohol Group Acceptor); Prostatic Neoplasms; RNA Interference; Signal Transduction; Taxoids; Time Factors; TOR Serine-Threonine Kinases; Transfection; Tumor Burden; Xenograft Model Antitumor Assays | 2016 |
Is quantitative coronary angiography reliable in assessing the late lumen loss of the everolimus-eluting bioresorbable polylactide scaffold in comparison with the cobalt-chromium metallic stent?
Topics: Absorbable Implants; Cardiovascular Agents; Chromium; Cobalt; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Humans; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Sirolimus | 2017 |
Dollars and stents: A brave new world.
Topics: Chromium; Cobalt; Cost-Benefit Analysis; Drug-Eluting Stents; Everolimus; Humans; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic; Stents | 2017 |
Comparison of clinical outcomes of coronary artery stent implantation in patients with end-stage chronic kidney disease including hemodialysis for three everolimus eluting (EES) stent designs: Bioresorbable polymer-EES, platinum chromium-EES, and cobalt c
Topics: Absorbable Implants; Aged; Chromium; Cobalt; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Male; Middle Aged; Percutaneous Coronary Intervention; Platinum; Renal Dialysis; Risk Factors; Trace Elements; Treatment Outcome | 2018 |
Early vascular responses to everolimus-eluting cobalt-chromium stent in the culprit lesions of st-elevation myocardial infarction: results from a multicenter prospective optical coherence tomography study (MECHANISM-AMI 2-week follow-up study).
Topics: Aged; Cardiovascular Agents; Chromium; Cobalt; Coronary Angiography; Coronary Vessels; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Prospective Studies; ST Elevation Myocardial Infarction; Tomography, Optical Coherence; Treatment Outcome | 2019 |
Five-year clinical outcomes of everolimus-eluting stents from the post marketing study of CoCr-EES (XIENCE V/PROMUS) in Japan.
Topics: Aged; Chromium; Cobalt; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Japan; Male; Middle Aged; Percutaneous Coronary Intervention; Product Surveillance, Postmarketing; Prospective Studies; Prosthesis Design; Registries; Survival Analysis; Treatment Outcome | 2019 |
Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk: A Patient-Level Stratified Analysis From Four Postapproval Studies.
Topics: Aged; Aged, 80 and over; Cause of Death; Chromium; Cobalt; Comorbidity; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Drug Therapy, Combination; Drug-Eluting Stents; Everolimus; Female; Hemorrhage; Hemorrhagic Disorders; Humans; Kaplan-Meier Estimate; Male; Metabolic Syndrome; Middle Aged; Mortality; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Polymers; Prevalence; Proportional Hazards Models; Prospective Studies; Registries; Smoking; Treatment Outcome | 2020 |
Vascular Response Occurring at 3 Months After Everolimus-Eluting Cobalt-Chromium Stent Implantation in Patients With ST-Segment Elevation Myocardial Infarction vs. Stable Coronary Artery Disease.
Topics: Chromium; Cobalt; Coronary Artery Disease; Drug-Eluting Stents; Everolimus; Humans; Percutaneous Coronary Intervention; Prospective Studies; ST Elevation Myocardial Infarction; Thrombosis; Tomography, Optical Coherence; Treatment Outcome | 2020 |